Alterity Therapeutics (ATHE) Debt Ratio (2011 - 2015)

Alterity Therapeutics (ATHE) recorded quarterly Debt Ratio of 0.0 in Q4 2015, up 5329528.13% quarter-over-quarter from 0.0 in Q2 2015, and down 99.27% on a YoY basis from 0.0 in Q4 2014.

Alterity Therapeutics (ATHE) Debt Ratio (2011 - 2015) Analysis & Trends

Alterity Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q4 2015.

  • In Q4 2015, Debt Ratio fell 99.27% year-over-year to 0.0; the TTM figure through Dec 2015 stood at 0.0 (down 99.27% YoY), while the FY2015 annual figure was 0.0, down 86.28% from the prior year.
  • Debt Ratio was 0.0 for Q4 2015 at Alterity Therapeutics, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.05 in Q2 2012 to a low of 0.0 in Q2 2015.
  • Historically, Debt Ratio has averaged 0.02 across 4 years, with a median of 0.02 in 2011.
  • The sharpest annual moves came in 2012 and 2015: Debt Ratio rose 15.87% in 2012, then slumped 99.27% in 2015.
  • A 4-year view of Debt Ratio shows it stood at 0.04 in 2011, then increased by 4.3% to 0.05 in 2012, then sank by 95.4% to 0.0 in 2014, then plunged by 99.27% to 0.0 in 2015.
  • The last three Debt Ratio figures came in at 0.0 (Q4 2015), 0.0 (Q2 2015), and 0.0 (Q4 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 0.05

Historic Data

Download Data
DateValue
Dec 31, 2015 0.00
Jun 30, 2015 0.00
Dec 31, 2014 0.00
Jun 30, 2012 0.05
Dec 31, 2011 0.04
Jun 30, 2011 0.04